Table 3.
Clinical features in our cohort of patients with CVID and autoimmune manifestations.
| Patient | Age (Years) | Sex (M/F) | Clinical Phenotype [2] | Autoimmune Disease |
|---|---|---|---|---|
| 1 | 30 | F | C, PL, E | ITP |
| 2 | 46 | M | C, PL | ITP, autoimmune neutropenia |
| 3 | 26 | F | I | Autoimmune gastritis |
| 4 | 56 | M | PL, E | Thyroiditis |
| 5 | 37 | M | C, PL, E | ITP, psoriasis |
| 6 | 54 | F | C, PL | ITP |
| 7 | 64 | M | I | Arthritis, thyroiditis |
| 8 | 59 | M | PL | Thyroiditis |
| 9 | 58 | M | C | AIHA |
| 10 | 50 | M | C, E | ITP, arthritis, coeliac disease |
| 11 | 74 | M | PL | Autoimmune gastritis, vitiligo |
| 12 | 75 | M | E | Vitiligo |
| 13 | 36 | F | C, PL | Autoimmune gastritis, AIHA |
| 14 | 43 | M | I | Alopecia |
| 15 | 57 | M | I | Arthritis |
| 16 | 71 | F | C, PL | Arthritis, ITP, psoriasis |
| 17 | 61 | M | C, PL | Autoimmune neutropenia |
| 18 | 50 | M | I | Arthritis |
| 19 | 27 | M | C, PL | Arthritis, other cytopenias |
| 20 | 65 | F | I | Arthritis, psoriasis |
| 21 | 58 | M | I | Arthritis |
| 22 | 47 | F | C, E | Arthritis, ITP |
| 23 | 69 | F | C, PL | ITP, AIHA |
| 24 | 67 | F | C, PL | ITP, AIHA, Autoimmune neutropenia |
| 25 | 53 | F | I | Arthritis |
| 26 | 58 | F | I | Vitiligo |
| 27 | 64 | F | I | Arthritis, Raynaud’s phenomenon |
| 28 | 52 | F | PL | Vitiligo, recurring oral ulcers, psoriasis |
| 29 | 76 | F | C, PL | Vitiligo, other cytopenias |
| 30 | 81 | F | PL | Vitiligo, arthritis |
| 31 | 45 | F | I | Erythema nodosum |
| 32 | 58 | F | C, PL | ITP, primary biliary cholangitis |
| 33 | 24 | M | C, PL, E | ITP |
| 34 | 30 | M | C, PL | ITP |
| 35 | 39 | F | I | Psoriasis |
| 36 | 30 | F | PL | Psoriasis |
| 37 | 32 | F | I | Psoriasis |
| 38 | 53 | F | PL | Psoriasis |
| 39 | 38 | M | PL | Psoriasis |
I, no other disease-related complications; C, cytopenias; PL, polyclonal lymphoproliferation; E, unexplained persistent enteropathy; ITP, immune thrombocytopenia; AIHA, Autoimmune hemolytic anemia.